Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

COO - Cooper Companies, Inc.


IEX Last Trade
105.67
-0.060   -0.057%

Share volume: 1,677,051
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST

PREVIOUS CLOSE
CHG
CHG%

$105.73
-0.06
-0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
11.74%
1 Month
14.07%
3 Months
17.18%
6 Months
11.87%
1 Year
11.04%
2 Year
46.74%
Key data
Stock price
$105.67
P/E Ratio 
61.95
DAY RANGE
$104.46 - N/A
EPS 
$1.70
52 WEEK RANGE
$75.94 - $106.95
52 WEEK CHANGE
$0.16
MARKET CAP 
21.057 B
YIELD 
N/A
SHARES OUTSTANDING 
199.156 M
DIVIDEND
$0.03
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
12/05/2024
BETA 
0.80
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,519,001
AVERAGE 30 VOLUME 
$1,103,692
Company detail
CEO: Albert White
Region: US
Website: https://www.coopercos.com/
Employees: 308
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

company overview the cooper companies, inc. ("cooper"​) is a global medical device company publicly traded on the nyse euronext (nyse:coo). cooper is dedicated to being a quality of life company™ with a focus on delivering shareholder value. cooper operates through two business units, coopervision and coopersurgical. coopervision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. coopersurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. headquartered in pleasanton, ca, cooper has approximately 9,000 employees with products sold in over 100 countries. for more information, please visit www.coopercos.com.

Recent news